PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
78.38%
Revenue growth of 78.38% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
140.18%
Gross profit growth of 140.18% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
12.00%
EBIT growth of 12.00% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
12.00%
Operating income growth of 12.00% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
14.27%
Net income growth of 14.27% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
13.68%
EPS growth of 13.68% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
13.68%
Diluted EPS growth of 13.68% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.10%
Positive OCF growth while Healthcare median is negative. Peter Lynch might see a strong relative advantage in operational efficiency.
-23.74%
Negative FCF growth while Healthcare median is -6.27%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-428.58%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-428.58%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-428.58%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-115.04%
Negative 10Y net income/share CAGR vs. Healthcare median of 1.26%. Seth Klarman might see a fundamental problem if peers maintain growth.
-115.04%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-115.04%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
123.15%
Equity/share CAGR of 123.15% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
123.15%
5Y equity/share CAGR > 1.5x Healthcare median of 5.80%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
123.15%
3Y equity/share CAGR > 1.5x Healthcare median of 11.20%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.45%
AR growth of 50.45% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
11.96%
Inventory growth of 11.96% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
-4.73%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-9.17%
Negative BV/share change while Healthcare median is -1.13%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.27%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.